Three pharmaceutical companies are poised to test whether new drugs can work against a wide range of cancers independently of where they originated — breast, prostate, liver, lung for the first time ever.
The drugs go after an aberration involving a cancer gene fundamental to tumour growth, the New York Times reported.Many scientists see this as the beginning of a new genetic age in cancer research.
No comments:
Post a Comment